Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Nowakowski

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
The American Journal of Tropical Medicine and Hygiene|May 7, 2008
The propensity of different Borrelia burgdorferi sensu stricto genotypes to cause disseminated infections in humansDaniel E Dykhuizen, Dustin Brisson, Sabina Sandigursky, et al.
BMC Infectious Diseases|October 28, 2015
Public health impact of strain specific immunity to Borrelia burgdorferiCamilo E Khatchikian, Robert B Nadelman, John Nowakowski, et al.
The American Journal of Medicine|August 2, 2003
Long-term follow-up of patients with culture-confirmed Lyme diseaseJohn Nowakowski, Robert B Nadelman, Rebecca Sell, et al.
Clinical and Diagnostic Laboratory Immunology|September 9, 2005
A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme BorreliosisMario T Philipp, Gary P Wormser, Adriana R Marques, et al.
Annals of Internal Medicine|May 6, 2003
Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trialGary P Wormser, Roshan Ramanathan, John Nowakowski, et al.
The Journal of Infectious Diseases|September 11, 2008
Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme diseaseGary P Wormser, Dustin Brisson, Dionysios Liveris, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2015
Long-term assessment of health-related quality of life in patients with culture-confirmed early Lyme diseaseGary P Wormser, Erica Weitzner, Donna McKenna, et al.
Journal of Clinical Microbiology|March 30, 2002
Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: correlation of results with clinical and laboratory findingsDionysios Liveris, Guiqing Wang, Gary Girao, et al.
Annals of Internal Medicine|May 4, 2005
Brief communication: hematogenous dissemination in early Lyme diseaseGary P Wormser, Donna McKenna, Jennafer Carlin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2009
Blood cultures for patients with extracutaneous manifestations of Lyme disease in the United StatesJohn Nowakowski, Donna McKenna, Robert B Nadelman, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
The American Journal of Tropical Medicine and Hygiene|May 7, 2008
The propensity of different Borrelia burgdorferi sensu stricto genotypes to cause disseminated infections in humansDaniel E Dykhuizen, Dustin Brisson, Sabina Sandigursky, et al.
BMC Infectious Diseases|October 28, 2015
Public health impact of strain specific immunity to Borrelia burgdorferiCamilo E Khatchikian, Robert B Nadelman, John Nowakowski, et al.
The American Journal of Medicine|August 2, 2003
Long-term follow-up of patients with culture-confirmed Lyme diseaseJohn Nowakowski, Robert B Nadelman, Rebecca Sell, et al.
Clinical and Diagnostic Laboratory Immunology|September 9, 2005
A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme BorreliosisMario T Philipp, Gary P Wormser, Adriana R Marques, et al.
Annals of Internal Medicine|May 6, 2003
Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trialGary P Wormser, Roshan Ramanathan, John Nowakowski, et al.
The Journal of Infectious Diseases|September 11, 2008
Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme diseaseGary P Wormser, Dustin Brisson, Dionysios Liveris, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2015
Long-term assessment of health-related quality of life in patients with culture-confirmed early Lyme diseaseGary P Wormser, Erica Weitzner, Donna McKenna, et al.
Journal of Clinical Microbiology|March 30, 2002
Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: correlation of results with clinical and laboratory findingsDionysios Liveris, Guiqing Wang, Gary Girao, et al.
Annals of Internal Medicine|May 4, 2005
Brief communication: hematogenous dissemination in early Lyme diseaseGary P Wormser, Donna McKenna, Jennafer Carlin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2009
Blood cultures for patients with extracutaneous manifestations of Lyme disease in the United StatesJohn Nowakowski, Donna McKenna, Robert B Nadelman, et al.
Pageof 4